The Damon Runyon Cancer Research Foundation Clinical Investigator Symposium
Monday, April 27, 2009
Presented by The Damon Runyon Cancer Research Foundation and The New York Academy of Sciences
This one-day symposium will commemorate the 10th year of the Damon Runyon Clinical Investigator Award. We will feature distinguished awardees and alumni of the program, who will speak about their groundbreaking discoveries in the area of translational cancer research.
In addition, the schedule will include Keynote Speaker Robert A. Weinberg, PhD, of the Whitehead Institute and MIT. Dr. Weinberg is a pioneer in cancer research, most widely known for his discovery of the first human oncogene (Ras). The day will culminate with a panel discussion entitled "Moving from Discovery through Development – The Evolving Relationship between Academia and Industry."
Join us for this excellent opportunity to learn about the latest advances by the brightest young physician-scientists in cancer research.
Scientific Organizing Committee
- Richard J. O'Reilly, Memorial Sloan-Kettering Cancer Center
- Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
- Bruce A. Chabner, Massachusetts General Hospital
- Patricia A. Ganz, University of California, Los Angeles
- Richard B. Gaynor, Eli Lilly and Company
- Hedvig Hricak, Memorial Sloan-Kettering Cancer Center
- William G. Kaelin, Jr., Dana-Farber Cancer Institute
- David M. Livingston, Dana-Farber Cancer Institute
The Damon Runyon Clinical Investigator Award supports young physician-scientists conducting patient-oriented cancer research. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments. The Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming independent clinical investigators.